Comment on “The Economics of Follow-On Drug Research and Development: Trends in Entry Rates and the Timing of Development”

Author： Hollis Aidan  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.23, Iss.12, 2005-01, pp. : 1187-1192

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Economics of Follow-On Drug Research and Development: Trends in Entry Rates and the Timing of Development – The Authors' Reply

By DiMasi Joseph A.   Paquette Cherie  

PharmacoEconomics, Vol. 23, Iss. 12, 2005-01 ,pp. : 1193-1202

Adis International

Access to resources Recommend Favorite

Health economics in drug development

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 412, 2003-01 ,pp. : 3-5

Adis International

Access to resources Recommend Favorite

Comment on: Dogs and monkeys in preclinical drug development: the challenge of reducing and replacing

By Brown Jeffrey  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 12, 2013-12 ,pp. : 1677-1678

Informa Healthcare

Access to resources Recommend Favorite

The Future Costs, Risks and Rewards of Drug Development: The Economics of Pharmacogenomics

By Cook Joseph  

PharmacoEconomics, Vol. 27, Iss. 5, 2009-05 ,pp. : 355-363

Adis International

Access to resources Recommend Favorite

Aptamers Building a Role in Research and Drug Development

By Adis International Limited  

Pharmaceutical & Diagnostic Innovation, Vol. 3, Iss. 1, 2005-01 ,pp. : 3-7

Adis International

Access to resources Recommend Favorite